This project addresses two overarching priorities on neurobehavioral research on HIV: (1) There is a need for a time efficient, sensitive and reliable method to assess HIV-1-associated neurocognitive disorder, especially in early phases of disease when most persons are medically asymptomatic. Existing approaches involve significant tradeoffs between time taken to assess a person and likelihood of detecting impairment. The recent development of a theory-driven computerized assessment (The Cambridge Neuropsychological Test Automated Battery (CANTAB)), which has been used successfully in detecting other forms of dementia, promises to be a useful advance methodologically. (2) Until recently, progress in understanding the neuropathogenesis of HIV has been hampered by lack of an appropriate animals model. The development of a Simian immunodeficiency virus (SIV) model in which Gold and Koob are capable of performing neurobehavioral testing of animals using a modified CANTAB approach presents an unparalleled opportunity for """"""""human/infrahuman primate translation"""""""".
Aim 1 : To determine if HIV-1 infection in humans and SIV infection in monkeys produce similar neurocognitive impairments. Using human and monkey versions of CANTAB we will compare whether the qualitative features of neurobehavioral impairment are similar, and whether progression of disease is accompanied by similar generalization from a """"""""fronto-striatal"""""""" to global impairment.
Aim 2 : To determine if CANTAB is a time-efficient, reliable, informative alternative to current lengthy neuropsychological (NP) assessments to detect and monitor HIV-1 neurocognitive disorders. Method Men and women will be recruited from the HNRC (60 AIDS, 60 HIV+ non-AIDS, and 60 HIV-controls). Subjects will receive CANTAB assessment annually for 5 years. Results of CANTAB will be related to the indepth NP and neuromedical assessments performed as part of the HNRC. Pattern and time related changes in CANTAB will be compared to similar data from monkeys in the Gold/Koob project. Significance As a result of these studies, we should be able to determine whether the SIV-infected monkeys represent a suitable animal neurobehavioral model of HIV CNS disease in humans, and whether CANTAB represents a suitable substitute, or even advance over, currently available lengthier NP assessments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
3P50MH047680-09S1
Application #
6111534
Study Section
Project Start
1998-03-15
Project End
1999-08-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Gruol, Donna L (2015) IL-6 regulation of synaptic function in the CNS. Neuropharmacology 96:42-54
Taffe, Michael A; Taffe, William J (2011) Rhesus monkeys employ a procedural strategy to reduce working memory load in a self-ordered spatial search task. Brain Res 1413:43-50
Sundstrom, Magnus; Chatterji, Udayan; Schaffer, Lana et al. (2008) Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology 371:394-404
Persidsky, Yuri; Fox, Howard (2007) Battle of animal models. J Neuroimmune Pharmacol 2:171-7
Taffe, Michael A; Weed, Michael R; Gutierrez, Tannia et al. (2004) Modeling a task that is sensitive to dementia of the Alzheimer's type: individual differences in acquisition of a visuo-spatial paired-associate learning task in rhesus monkeys. Behav Brain Res 149:123-33
Weed, Michael R; Gold, Lisa H; Polis, Ilham et al. (2004) Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection. AIDS Res Hum Retroviruses 20:77-89
Taffe, Michael A; Huitron-Resendiz, Salvador; Schroeder, Richard et al. (2003) MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. Pharmacol Biochem Behav 76:141-52
Campbell, I L (2002) Cytokine-mediated inflammation and other actions in the central nervous system. Ernst Schering Res Found Workshop :61-83
Wang, J; Asensio, V C; Campbell, I L (2002) Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice. Curr Top Microbiol Immunol 265:23-48
Hart, Richard A; Billaud, Jean-Noel; Choi, Sam J et al. (2002) Effects of 1,8-diaminooctane on the FIV Rev regulatory system. Virology 304:97-104

Showing the most recent 10 out of 219 publications